Prostate cancer imaging gets a direct hit: artery injection may sharpen scans

NCT ID NCT07656337

Not yet recruiting Knowledge-focused Sponsor: Lithuanian University of Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether injecting a radioactive tracer directly into the prostate artery improves imaging compared to standard arm injection in 10 men with high-risk prostate cancer. The goal is to see if this method gives clearer pictures and helps predict the right radiation dose for future treatments. Participants will have two scans and then proceed with standard surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 68Ga-PSMA
What this could lead to: If successful, this could lead to more precise imaging and personalized radiation dosing for prostate cancer treatment.
What could go wrong: This is a very small, early-phase study with only 10 participants, so results may not apply broadly. The intra-arterial procedure carries additional risks like bleeding or vessel damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE ADENOCARCINOMA PROSTATE CANCER

Contacts and locations

Locations

Lithuanian University of Health Sciences Kaunas Clinics

Kaunas, LT-50103, Lithuania

More trials for these conditions

Other studies related to the condition(s) this trial covers.